Movicol

Macrogol 3350, the active ingredient in Movicol, is a osmotic laxative presented as a oral solution for oral use. It treats constipation and faecal impaction in adults and children. GNH USA supplies Movicol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol is an osmotic laxative used to manage conditions affecting bowel motility and stool consistency.

Constipation: softens stool and facilitates regular bowel movements. Faecal impaction: helps break down hardened stool masses for easier evacuation. Chronic idiopathic constipation: provides long‑term relief by maintaining stool hydration.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Nausea: mild to moderate sensation of wanting to vomit. - Flatulence: increased intestinal gas. - Diarrhoea: loose, watery stools. - Abdominal pain: cramping or discomfort. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal levels of sodium, potassium, or chloride. - Severe dehydration: marked loss of body fluids. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: persistent or worsening pain requiring medical attention.

Before using Movicol, consider the following precautions: - Renal function assessment: evaluate kidney health to avoid fluid overload. - Electrolyte monitoring: check serum electrolytes, especially in long‑term use. - Bowel obstruction: avoid if there is known mechanical blockage. - Elderly patients: start with lower doses and monitor tolerance. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Movicol may interact with other medications as follows:

Major Interactions (Avoid): - Loop diuretics: increased risk of electrolyte disturbances. - Mineralocorticoid therapy: may exacerbate sodium and water retention. - Other osmotic laxatives: additive effect leading to severe dehydration.

Moderate Interactions (Monitor Closely): - Antacids containing aluminium or magnesium: may alter absorption. - NSAIDs: potential for reduced renal clearance when combined. - ACE inhibitors: monitor blood pressure and renal function.